Patents Assigned to The Trustees of Columbia University
-
Publication number: 20250252263Abstract: Disclosed are systems, methods, and other implementations, including a method for detecting machine-generated content that includes receiving written source input at a machine learning system configured to transform written content into resultant transformed content, and generating by the machine learning system one or more rewritten versions of the written source input, with the one or more rewritten versions being semantically similar to the written source input. The method further includes deriving one or more rewriting change measurements, for the one or more rewritten versions, representing extent of differences between the one or more rewritten versions and the written source input, and determining likelihood that the written source input was machine generated based at least on the derived one or more rewriting change measurements.Type: ApplicationFiled: January 28, 2025Publication date: August 7, 2025Applicant: The Trustees of Columbia University in the City of New YorkInventors: Junfeng YANG, Chengzhi MAO, Carl VONDRICK, Wei HAO
-
Patent number: 12379326Abstract: An apparatus includes a main body, circuit assembly, lens, and clamping assembly. The main body includes an aperture that receives a wafer configured to receive a sample under study. The main body is configured to support the circuit assembly, which includes illumination sources that emit light of different colors such that total internal reflection is generated in the wafer. The main body is configured to provide support for the lens, and the clamping assembly mechanically coupled to the main body such that the lens is selectively positionable with respect to a camera lens. A microscopy imaging apparatus includes an illumination source, wafer, and charge-coupled device. The illumination source is configured to emit white light such that total internal reflection is generated in the wafer.Type: GrantFiled: May 16, 2022Date of Patent: August 5, 2025Assignees: The Trustees of Columbia University in the City of New York, United States Department of EnergyInventors: Mingzhao Liu, Justine E. Haupt, Connie-Rose Mai Deane, Oleg Gang
-
Patent number: 12372583Abstract: An approach to control or monitoring of battery operation makes use of a recurrent neural network (RNN), which receives one or more battery attributes for a Lithium ion (Li-ion) battery, and determines, based on the received one or more battery attributes, a state-of-charge (SOC) estimate for the Li-ion battery.Type: GrantFiled: October 8, 2021Date of Patent: July 29, 2025Assignees: The Trustees of Columbia University in the City of New York, McMaster UniversityInventors: Ephram Chemali, Matthias Preindl
-
Patent number: 12372585Abstract: An approach to control or monitoring of battery operation makes use of an artificial neural network (ANN), which receives one or more battery attributes for a Lithium ion (Li-ion) battery, and determines, based on the received one or more battery attributes, a state-of-charge (SOC) and/or a state-of-health (SOH) estimate for the Li-ion battery. The ANN includes at least one of a recurrent neural network (RNN) and a convolutional neural network (CNN), and the series of values of the battery attributes includes at one of battery voltage values, battery current values, and battery temperature values.Type: GrantFiled: March 7, 2023Date of Patent: July 29, 2025Assignees: The Trustees of Columbia University in the City of New York, McMaster UniversityInventors: Ephram Chemali, Matthias Preindl
-
Patent number: 12369010Abstract: A method for practicing precision medicine comprising providing, to a blockchain platform, each of clinical data and genetic data, providing the blockchain platform, the blockchain platform having a first data structure comprising clinical data and a second data structure comprising genetic data, harmonizing the first and second data structures, creating at least one cohort based on the harmonized first and second data structures, and identifying at least one relationship between the clinical data and the genetic data in each of the at least one cohort.Type: GrantFiled: January 23, 2024Date of Patent: July 22, 2025Assignee: The Trustees of Columbia University in the City of New YorkInventors: Gamze Gürsoy, Ahmed Elhussein
-
Patent number: 12357595Abstract: The present invention relates to noninvasive microbiome analyses of Barrett's esophagus (BE) patients in which changes in the relative abundance of certain bacteria indicate a disease likelihood or pathogenic state. Additional aspects of the present invention relate to manipulating the microbiome to treat or prevent BE and related conditions. Embodiments also include monitoring for development of disease or monitoring treatment for prevention or elimination of disease states.Type: GrantFiled: May 12, 2023Date of Patent: July 15, 2025Assignee: The Trustees of Columbia University in the City of New YorkInventor: Julian Abrams
-
Patent number: 12360845Abstract: Disclosed are methods, systems, devices, circuits. and other implementations, including a method for error identification and correction that includes obtaining from a memory device coded input data, the coded input data previously encoded by multiplying a source data element by a pre-determined multiplier, and stored in the memory device, and performing a decoding operation on the coded input data obtained from the memory device, with the decoding operation including at least a modulo operation, to derive a resultant decoded data element and a remainder portion. The method further includes determining whether the coded input data includes a corrupted portion based on a value of the remainder portion.Type: GrantFiled: June 23, 2022Date of Patent: July 15, 2025Assignee: The Trustees of Columbia University in the City of New YorkInventors: Lakshminarasimhan Sethumadhavan, Evgeny Manzhosov
-
Publication number: 20250205389Abstract: Medical devices having engineered mechanically functional cartilage from adult human mesenchymal stem cells and method for making same.Type: ApplicationFiled: July 29, 2024Publication date: June 26, 2025Applicant: The Trustees of Columbia University in the City of New YorkInventors: Sarindr BHUMIRATANA, Gordana VUNJAK-NOVAKOVIC
-
Publication number: 20250204788Abstract: Systemic lupus erythematosus (SLE) can be diagnosed by affixing a plurality of light sources and a plurality of light detectors against the subject's body near a joint, and sequentially transmitting light from each of the plurality of light sources into the subject's body. Signals are acquired from each of the plurality of light detectors. The rise time of the acquired signals that occurs in response to an inflation of a pressure cuff is determined, and an indication of whether the joint is affected by SLE is made based on the determined rise time. In some embodiments, a plateau time of the acquired signals is also acquired, and the indication of whether the joint is affected by SLE is made based on the determined rise time and the determined plateau time.Type: ApplicationFiled: November 4, 2024Publication date: June 26, 2025Applicant: The Trustees of Columbia University in City of New YorkInventors: Andreas H. HIELSCHER, Alessandro Marone, Ioannis Kymissis, Youngwan Kim, Anca D. Askanase
-
Patent number: 12329726Abstract: Biomarkers for assessing the efficacy of prophylactic treatments of stress-induced affective disorders are provided.Type: GrantFiled: September 28, 2022Date of Patent: June 17, 2025Assignees: The Trustees of Columbia University in the City of New York, BPG BIO, INC, The Research Foundation for Mental Hygiene, IncInventors: Josephine Cecelia McGowan, Christine Ann Denny, Michael Kiebish
-
Patent number: 12331292Abstract: In certain embodiments, the present systems and methods use Tn7-like transposons that encode CRISPR-Cas systems for programmable, RNA-guided DNA integration. For example, the CRISPR-Cas machinery directs the Tn7 transposon-associated proteins to integrate DNA downstream of a target site (e.g., a genomic target site) recognized by a guide RNA (gRNA).Type: GrantFiled: June 26, 2020Date of Patent: June 17, 2025Assignee: The Trustees of Columbia University in the City of New YorkInventors: Samuel Henry Sternberg, Sanne Eveline Klompe
-
Publication number: 20250186257Abstract: One aspect of the invention provides a method of treating a cornea. The method includes controlling a light source to apply light energy pulses to a single corneal layer selected from the group consisting of: an anterior corneal layer and a posterior corneal layer. The light energy pulses are below an optical breakdown threshold for the cornea and ionize water molecules within the treated corneal layer to generate reactive oxygen species that cross-link collagen within the single corneal layer. Another aspect of the invention provides a method of treating a cornea. The method includes controlling a light source to apply light energy pulses to at least a corneal stroma layer of a cornea. The light energy pulses are below an optical breakdown threshold for the cornea and ionize water molecules within the treated corneal stromal layer to generate reactive oxygen species that cross-link collagen within the cornea.Type: ApplicationFiled: July 19, 2024Publication date: June 12, 2025Applicant: The Trustees of Columbia University in the City of New YorkInventor: Sinisa VUKELIC
-
Patent number: 12326622Abstract: Provided are devices that have a distal portion configured to be implanted in a brain of a subject. The distal portion includes one or more emitters configured to emit light in the visible spectrum. The device includes a proximal portion configured to be external to the brain of the subject while the distal portion is implanted, wherein the proximal portion includes at least one waveguide in optical communication with the one or more emitters. The at least one waveguide defines a cross-sectional width less than 500 nm. The at least one waveguide is optionally coupled to a heating element that is optionally configured to adjust a phase of light within the at least one waveguide.Type: GrantFiled: January 25, 2018Date of Patent: June 10, 2025Assignees: The Trustees of Columbia University in the City of New York, Cold Spring Harbor LaboratoryInventors: Michal Lipson, Aseema Mohanty, Mohammad Amin Tadayon, Adam Kepecs, Qian Li, Xingchen Ji, Christine P. Hendon, Xinwen Yao
-
Patent number: 12324807Abstract: Described herein are compositions and methods for treating a disease or disorder associated with PI3K signaling. For example, such compositions can include use of modulators of glucose metabolism, use of at least one kinase in the insulin-receptor/PI3K/AKT/mTOR pathway, and/or use of diet that influences the subject's metabolic state.Type: GrantFiled: May 31, 2019Date of Patent: June 10, 2025Assignees: Cornell University, The Trustees of Columbia UniversityInventors: Lewis C. Cantley, Benjamin Hopkins, Marcus Goncalves, Siddhartha Mukherjee
-
Patent number: 12312618Abstract: The present disclosure provides, inter alia, a recombinant engineered deubiquitinase (DUB) and methods for treating or ameliorating an inherited ion channelopathy, such as long QT syndrome, Brugada syndrome, or cystic fibrosis, in a subject. Further provided are methods for screening mutations causing such inherited ion channelopathies for a trafficking-deficient mutation that is treatable by the recombinant engineered DUB disclosed herein.Type: GrantFiled: August 6, 2024Date of Patent: May 27, 2025Assignee: The Trustees of Columbia University in the City of New YorkInventors: Henry M. Colecraft, Scott Kanner
-
Publication number: 20250164380Abstract: Biological cells can be identified and recovered from a sample by pumping the sample through a flow channel so that the sample flows through the flow channel with a non-turbulent flow (e.g., a laminar flow). A plurality of images of the sample are captured as the sample passes through the flow channel. These images are analyzed to determine which portions of the sample include a target biological cell. Portions of the sample that were determined to include a target biological cell are routed into at least one first container, and portions of the sample that were not determined to include a target biological cell are routed to at least one second destination (e.g., one or more second containers).Type: ApplicationFiled: January 24, 2025Publication date: May 22, 2025Applicant: The Trustees of Columbia University in the City of New YorkInventors: Samuel Z. WILLIAMS, Hemant Suryawanshi
-
Patent number: 12285464Abstract: The present invention relates to methods and compositions for specifically modulating the Hippo pathway transcription factor TAZ (WWTR1), as a therapeutic target for inhibiting or preventing liver conditions including the progression of steatosis-to-NASH in a patient.Type: GrantFiled: April 18, 2017Date of Patent: April 29, 2025Assignees: The Trustees of Columbia University in the City of New York, The Brigham and Women's Hospital, Inc.Inventors: Ira Tabas, Xiaobo Wang, Omid Farokhzad, Xiaoding Xu
-
Publication number: 20250127826Abstract: Orally-deliverable programmable bacteria cells that colonize colorectal tumors and produce diagnostic and therapeutic molecules, as well as related compositions and methods.Type: ApplicationFiled: November 4, 2024Publication date: April 24, 2025Applicant: The Trustees of Columbia University in the City of New YorkInventors: Tal DANINO, Candice GURBATRI
-
Patent number: 12280115Abstract: Cytokine-bisphosphonate conjugates and methods of use thereof in muscle functions.Type: GrantFiled: April 9, 2024Date of Patent: April 22, 2025Assignees: The Trustees of Columbia University in the City of New York, William Marsh Rice UniversityInventors: Gerard Karsenty, Julian Berger, Han Xiao
-
Patent number: RE50413Abstract: An insulated heating-unit cover having an opening to permit air to circulate around the heating-source when a vent disposed at the top of the cover is opened, allowing heat into a space. The cover can include a heating-unit temperature sensor disposed within a space covered by the cover and a controller in wireless communication with a space temperature sensor located at a distance away from the heating-unit. The controller can be configured to operate an actuator such that the vent is open when the space temperature sensor indicates that the ambient temperature is below a set point temperature and such that the vent is closed when the ambient temperature is greater than the set point temperature. The controller can communicate with a plurality of other similar controllers and a central server to effect changes in the output of a central heating source coupled to a plurality of individual heating-units.Type: GrantFiled: January 23, 2020Date of Patent: May 6, 2025Assignee: The Trustees of Columbia University in the City of New YorkInventors: Ioannis Kymissis, Marshall Cox, John Sarik